Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.

Cancer Synoptic Reporting Project Group

21 April at 16:00 - 18:30 UTC

Attendees

Scott Campbell 

 @Apologies


Discussion items

ItemDescriptionOwnerNotesAction
1Conflict of Interest
  •  
2Concepts promoted to task and in queue for promotion
  1. Histologic type of neoplasm of X (64 new observable entities)
  2. Histologic grade of neoplasm of X (81 concepts)
  3. Anatomic locations invaded by neoplasm of X (90)
  4. Perineural and Lymphovascular invasion (63)
  5. Lymph node concepts (22)
  6. Surgical margins involved by neoplasm of X (50)
  7. Dimension concepts (50)

3Concepts in review for inclusion in taskScott Campbell
  1. Surgical margins (presence of involvement) moved to review (190+ concepts)
  1. How to reflect margins that reference anatomical location 
  2. JCA will allow editorial exception for anatomic structure in FSN of surgical margin when dictated by specific, limited cases defined by pathologists
43Grade finding (finding)

Discuss clinical finding concepts in existing SI content.  To inactivate or not Follow up ?

Jim Case to draft letter to Jeremy Rogers to discuss UK use of Grade (findings) in light of Grade (qualifiers) used in CSRWG.  Suzanne Santamaria to pre-review letter.

with UK use case

  1. Finding concepts not used in primary care.  Question outstanding for non-primary care use.
  2. looks like we can deprecate the findings.  
54Next conceptsSurgical margins (presence of involvement)

  1. Tumor buds and tumor deposits
  2. FIGO and other stage/grades?
  3. Tumor focality
  4. Treatment effect
  5. Depth of invasion
  6. Other areas
  1. ENETS
  2. FIGO
65Business meeting

I&E documents to do and review

Cancer Synoptic Reporting
7Histology discussion

Agenda items:

  • Review of specific concepts
  • Discussion of next steps?
  • Review of I&E documents
    Removal of 86049000 |Malignant neoplasm, primary (morphologic abnormality)| and similar high-level concepts.  Challenge for this group and disorders. 

    Removal of concepts like: 2092003 |Malignant melanoma, no International Classification of Diseases for Oncology subtype (morphologic abnormality)|
    1. How to model primary, metastatic and unknown processes in Observable entity concepts and in disorders

    2. Impact on links to ICD-O-3 behavior codes

    3. Impact on ICD-O-3 histology codes

    Note:  primary/secondary/metastatic/unknown/post-treatment tumors discussion needs to move back to editorial advisory group.  FSN implications and definitions....more discussion needed.  

    How does this impact grouper concepts


    Meeting Files

    Attachments




    Previous Meetings

    Content Report Table
    maxResults12
    showCommentsCounttrue
    spaces@self
    labelsmeeting-agenda